Abstract:
BACKGROUND:Imiquimod (IMQ) produces a cutaneous phenotype in mice frequently studied as an acute model of human psoriasis. Whether this phenotype depends on strain or sex has never been systematically investigated on a large scale. Such effects, however, could lead to conflicts among studies, while further impacting study outcomes and efforts to translate research findings. METHODS:RNA-seq was used to evaluate the psoriasiform phenotype elicited by 6 days of Aldara (5% IMQ) treatment in both sexes of seven mouse strains (C57BL/6 J (B6), BALB/cJ, CD1, DBA/1 J, FVB/NJ, 129X1/SvJ, and MOLF/EiJ). RESULTS:In most strains, IMQ altered gene expression in a manner consistent with human psoriasis, partly due to innate immune activation and decreased homeostatic gene expression. The response of MOLF males was aberrant, however, with decreased expression of differentiation-associated genes (elevated in other strains). Key aspects of the IMQ response differed between the two most commonly studied strains (BALB/c and B6). Compared with BALB/c, the B6 phenotype showed increased expression of genes associated with DNA replication, IL-17A stimulation, and activated CD8+ T cells, but decreased expression of genes associated with interferon signaling and CD4+ T cells. Although IMQ-induced expression shifts mirrored psoriasis, responses in BALB/c, 129/SvJ, DBA, and MOLF mice were more consistent with other human skin conditions (e.g., wounds or infections). IMQ responses in B6 mice were most consistent with human psoriasis and best replicated expression patterns specific to psoriasis lesions. CONCLUSIONS:These findings demonstrate strain-dependent aspects of IMQ dermatitis in mice. We have shown that IMQ does not uniquely model psoriasis but in fact triggers a core set of pathways active in diverse skin diseases. Nonetheless, our findings suggest that B6 mice provide a better background than other strains for modeling psoriasis disease mechanisms.
journal_name
Genome Medjournal_title
Genome medicineauthors
Swindell WR,Michaels KA,Sutter AJ,Diaconu D,Fritz Y,Xing X,Sarkar MK,Liang Y,Tsoi A,Gudjonsson JE,Ward NLdoi
10.1186/s13073-017-0415-3subject
Has Abstractpub_date
2017-03-09 00:00:00pages
24issue
1issn
1756-994Xpii
10.1186/s13073-017-0415-3journal_volume
9pub_type
杂志文章相关文献
Genome Medicine文献大全abstract:BACKGROUND:Retinoid therapy is widely employed in clinical oncology to differentiate malignant cells into their more benign counterparts. However, certain high-risk cohorts, such as patients with MYCN-amplified neuroblastoma, are innately resistant to retinoid therapy. Therefore, we employed a precision medicine approa...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-017-0407-3
更新日期:2017-02-10 00:00:00
abstract:BACKGROUND:The HHIP gene, encoding Hedgehog interacting protein, has been implicated in chronic obstructive pulmonary disease (COPD) by genome-wide association studies (GWAS), and our subsequent studies identified a functional upstream genetic variant that decreased HHIP transcription. However, little is known about ho...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-015-0137-3
更新日期:2015-02-14 00:00:00
abstract:BACKGROUND:Preterm birth confers a high risk of adverse long term health outcomes for survivors, yet the underlying molecular mechanisms are unclear. We hypothesized that effects of preterm birth can be mediated through measurable epigenomic changes throughout development. We therefore used a longitudinal birth cohort ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm500
更新日期:2013-10-18 00:00:00
abstract:BACKGROUND:Despite the increasing recognition that microbial communities within the human body are linked to health, we have an incomplete understanding of the environmental and molecular interactions that shape the composition of these communities. Although host genetic factors play a role in these interactions, these...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-018-0515-8
更新日期:2018-01-29 00:00:00
abstract:BACKGROUND:Establishing the cancer type and site of origin is important in determining the most appropriate course of treatment for cancer patients. Patients with cancer of unknown primary, where the site of origin cannot be established from an examination of the metastatic cancer cells, typically have poor survival. H...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-017-0493-2
更新日期:2017-11-28 00:00:00
abstract::Rett syndrome is a profound neurological disorder caused by mutations in the MECP2 gene, but preclinical research has indicated that it is potentially treatable. Progress towards this goal depends on the development of increasingly relevant model systems and on our improving knowledge of MeCP2 function in the brain. ...
journal_title:Genome medicine
pub_type: 信件,评审
doi:10.1186/s13073-017-0411-7
更新日期:2017-02-17 00:00:00
abstract::The pioneering work of Jean Dausset on the HLA system established several principles that were later reflected in the Human Genome Project and contributed to the foundations of predictive, preventive, personalized and participatory (P4) medicine. To effectively develop systems medicine, we should take advantage of the...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm178
更新日期:2010-08-26 00:00:00
abstract:BACKGROUND:Intertumoral heterogeneity represents a significant hurdle to identifying optimized targeted therapies in gastric cancer (GC). To realize precision medicine for GC patients, an actionable gene alteration-based molecular classification that directly associates GCs with targeted therapies is needed. METHODS:A...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-017-0484-3
更新日期:2017-10-31 00:00:00
abstract::The cancer genome is highly complex, with hundreds of point mutations, translocations, and chromosome gains and losses per tumor. To understand the effects of these alterations, precise models are needed. Traditional approaches to the construction of mouse models are time-consuming and laborious, requiring manipulatio...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/s13073-015-0178-7
更新日期:2015-06-09 00:00:00
abstract::Considerable progress has been made in identifying genetic risk factors for idiosyncratic adverse drug reactions in the past 30 years. These reactions can affect various tissues and organs, including liver, skin, muscle and heart, in a drug-dependent manner. Using both candidate gene and genome-wide association studie...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/gm409
更新日期:2013-01-29 00:00:00
abstract::The identification of somatic mosaicism in the brain lends a new perspective to our understanding of the role of gene and environment interactions in psychiatric disease risk. Somatic mutations, such as retrotransposon insertions, that are precipitated by modern environmental factors may alter neuronal function and ne...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-016-0317-9
更新日期:2016-05-23 00:00:00
abstract::Whole genome sequencing is increasingly used to study phenotypic variation among infectious pathogens and to evaluate their relative transmissibility, virulence, and immunogenicity. To date, relatively little has been published on how and how many pathogen strains should be selected for studies associating phenotype a...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-014-0101-7
更新日期:2014-11-15 00:00:00
abstract:BACKGROUND:Metabolomics, the non-targeted interrogation of small molecules in a biological sample, is an ideal technology for identifying diagnostic biomarkers. Current tissue extraction protocols involve sample destruction, precluding additional uses of the tissue. This is particularly problematic for high value sampl...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm332
更新日期:2012-04-30 00:00:00
abstract:BACKGROUND:For circadian medicine to influence health, such as when to take a drug or undergo a procedure, a biomarker of molecular clock phase is required--one that is easily measured and generalizable across a broad population. It is not clear that any circadian biomarker yet satisfies these criteria. METHODS:We ana...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00768-9
更新日期:2020-08-21 00:00:00
abstract::As many personal genomes are being sequenced, collaborative analysis of those genomes has become essential. However, analysis of personal genomic data raises important privacy and confidentiality issues. We propose a methodology for federated analysis of sequence variants from personal genomes. Specific base-pair posi...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-014-0071-9
更新日期:2014-09-17 00:00:00
abstract::The analysis of the genomic distribution of viral vector genomic integration sites is a key step in hematopoietic stem cell-based gene therapy applications, allowing to assess both the safety and the efficacy of the treatment and to study the basic aspects of hematopoiesis and stem cell biology. Identifying vector int...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-014-0067-5
更新日期:2014-09-03 00:00:00
abstract::The zebrafish model is rapidly gaining prominence in the study of development, hematopoiesis, and disease. The zebrafish provides distinct advantages over other vertebrate models during early embryonic development by producing transparent, externally fertilized embryos. Embryonic zebrafish are easily visualized and ma...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm299
更新日期:2011-12-29 00:00:00
abstract::Cutaneous malignancies, especially malignant melanoma, exhibit great genetic heterogeneity. As a result, some individuals and families have particularly increased risk due to genetic predisposition to the disease. The susceptibility alleles range from rarely occurring, heritable, high-risk variants to ubiquitously occ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm95
更新日期:2009-10-27 00:00:00
abstract::We describe a method that enables the multiplex screening of a pool of many different donor cell lines. Our method accurately predicts each donor proportion from the pool without requiring the use of unique DNA barcodes as markers of donor identity. Instead, we take advantage of common single nucleotide polymorphisms,...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-018-0541-6
更新日期:2018-04-19 00:00:00
abstract::Selective inhibitors of the kinases BRAF and MEK for the treatment of patients with otherwise refractory BRAF mutant melanoma have demonstrated impressive efficacy, and combination treatment with these agents may prove to be even more effective. However, these drugs are not curative, mainly because of the relatively r...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm547
更新日期:2014-04-28 00:00:00
abstract:BACKGROUND:The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their validation and up-take into...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm385
更新日期:2012-11-12 00:00:00
abstract:BACKGROUND:Alzheimer's disease affects ~13% of people in the United States 65 years and older, making it the most common neurodegenerative disorder. Recent work has identified roles for environmental, genetic, and epigenetic factors in Alzheimer's disease risk. METHODS:We performed a genome-wide screen of DNA methylat...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-015-0258-8
更新日期:2016-01-19 00:00:00
abstract::Coinciding with the release of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, two recently published molecular genetics analyses suggest large overlaps in genetic liability to schizophrenia, bipolar disorder and major depressive disorder. This indicates that a broader category of sever...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm501
更新日期:2013-10-25 00:00:00
abstract::To help overcome the bottlenecks that limit the development of diagnostic and therapeutic products, academic and industrial researchers, patient organizations and charities, and regulatory and funding institutions should redefine the basis for sharing the knowledge collected in large-scale clinical and experimental st...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm29
更新日期:2009-03-04 00:00:00
abstract::The number of metabolites identified in human cerebrospinal fluid (CSF) has steadily increased over the past 5 years, and in this issue of Genome Medicine David Wishart and colleagues provide a comprehensive update that brings the number of metabolites listed in the CSF metabolome database to 476 compounds. There is n...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm338
更新日期:2012-04-30 00:00:00
abstract:BACKGROUND:Enterococcus faecium is a commensal of the gastrointestinal tract of animals and humans but also a causative agent of hospital-acquired infections. Resistance against glycopeptides and to vancomycin has motivated the inclusion of E. faecium in the WHO global priority list. Vancomycin resistance can be confer...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00825-3
更新日期:2021-01-20 00:00:00
abstract:UNLABELLED:Bibliographic records in the PubMed database of biomedical literature are annotated with Medical Subject Headings (MeSH) by curators, which summarize the content of the articles. Two recent publications explain how to generate profiles of MeSH terms for a set of bibliographic records and to use them to defin...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm382
更新日期:2012-10-30 00:00:00
abstract::Systems biology has matured considerably as a discipline over the last decade, yet some of the key challenges separating current research efforts in systems biology and clinically useful results are only now becoming apparent. As these gaps are better defined, the new discipline of systems medicine is emerging as a tr...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm88
更新日期:2009-09-29 00:00:00
abstract:BACKGROUND:Based on promising phase II data, the histone deacetylase inhibitor entinostat is in phase III trials for patients with metastatic estrogen receptor-positive breast cancer. Predictors of sensitivity and resistance, however, remain unknown. METHODS:A total of eight cell lines and nine mouse models of breast ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-018-0597-3
更新日期:2018-11-30 00:00:00
abstract:BACKGROUND:Comprehensive molecular profiling has revealed somatic variations in cancer at genomic, epigenomic, transcriptomic, and proteomic levels. The accumulating data has shown clearly that molecular phenotypes of cancer are complex and influenced by a multitude of factors. Conventional unsupervised clustering appl...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00804-8
更新日期:2020-12-03 00:00:00